Detailansicht

Wissensnetz

Person

Bernd Wullich (1960-)

Arzt

Name	Bernd Wullich
Zeit	1960- (Lebensdaten)
Ort	Deutschland
Akademischer Grad bzw. Titel	Prof. Dr. med.
Beruf	Arzt (charakteristischer Beruf)
Variante	B. Wullich
Weitere Angaben	seit 2007 Direktor der Urologischen Klinik am Universitätsklinik Erlangen
Datensatztyp	Person
GND-Nummer	110835794
Datensatz-ID	110835794
Beteiligt an alle anzeigen Multicenter evaluation of complex urinary diversion for renal transplantation: outcomes of complex surgical solutions Combined miR-486 and GP88 (Progranulin) Serum Levels Are Suggested as Supportive Biomarkers for Therapy Decision in Elderly Prostate Cancer Patients Integration of Spatial PD-L1 Expression with the Tumor Immune Microenvironment Outperforms Standard PD-L1 Scoring in Outcome Prediction of Urothelial Cancer Patients Characterization of the expression and immunological impact of the transcriptional activator CREB in renal cell carcinoma RNA Sequencing of Collecting Duct Renal Cell Carcinoma Suggests an Interaction between miRNA and Target Genes and a Predominance of Deregulated Solute Carrier Genes Untersuchungen zur Psychoonkologie urologischer Tumorerkrankungen Differences in the frequencies of HLA-class I and II alleles between German patients with renal cell carcinoma and healthy controls ERBB2 Expression as Potential Risk-Stratification for Early Cystectomy in Patients with pT1 Bladder Cancer and Concomitant Carcinoma in situ How Octogenarians with Bladder Cancer Are Treated in a Maximum-Care Hospital: The Real-Life Experience Results of Renal Transplantation on Alloplastic Arterial Grafts Analysis and classification of oncology activities on the way to workflow based single source documentation in clinical information systems Analysis and classification of oncology activities on the way to workflow based single source documentation in clinical information systems Frequency of TERT Promoter Mutations in Prostate Cancer Gonadotropin-releasing hormone antagonists versus standard androgen suppression therapy for advanced prostate cancer A systematic review with meta-analysis Gonadotropin-releasing hormone antagonists versus standard androgen suppression therapy for advanced prostate cancer: A systematic review with meta-analysis Prognostic impact of urokinase-type plasminogen activator system components in clear cell renal cell carcinoma patients without distant metastasis Role of miRs in immune suppression Prognostic impact of urokinase-type plasminogen activator system components in clear cell renal cell carcinoma patients without distant metastasis Genetik von Krankheiten des Urogenitalsystems Genetik von Krankheiten des Urogenitalsystems : mit 36 Tabellen Heilung von Gastroentero-Anastomosen und Bauchdeckenwunden unter perioperativer Gabe der Zytostatika-Kombination FAM (5-Fluor-Uracil [Fluor-Uracil], Adriamycin, Mitomycin C) : e. biomechan. u. histolog. Unters. an Wistar-Ratten

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Bernd Wullich (1960-)

Multicenter evaluation of complex urinary diversion for renal transplantation: outcomes of complex surgical solutions

Combined miR-486 and GP88 (Progranulin) Serum Levels Are Suggested as Supportive Biomarkers for Therapy Decision in Elderly Prostate Cancer Patients

Integration of Spatial PD-L1 Expression with the Tumor Immune Microenvironment Outperforms Standard PD-L1 Scoring in Outcome Prediction of Urothelial Cancer Patients

Characterization of the expression and immunological impact of the transcriptional activator CREB in renal cell carcinoma

RNA Sequencing of Collecting Duct Renal Cell Carcinoma Suggests an Interaction between miRNA and Target Genes and a Predominance of Deregulated Solute Carrier Genes

Untersuchungen zur Psychoonkologie urologischer Tumorerkrankungen

Differences in the frequencies of HLA-class I and II alleles between German patients with renal cell carcinoma and healthy controls

ERBB2 Expression as Potential Risk-Stratification for Early Cystectomy in Patients with pT1 Bladder Cancer and Concomitant Carcinoma in situ

How Octogenarians with Bladder Cancer Are Treated in a Maximum-Care Hospital: The Real-Life Experience

Results of Renal Transplantation on Alloplastic Arterial Grafts

Analysis and classification of oncology activities on the way to workflow based single source documentation in clinical information systems

Analysis and classification of oncology activities on the way to workflow based single source documentation in clinical information systems

Frequency of TERT Promoter Mutations in Prostate Cancer

Gonadotropin-releasing hormone antagonists versus standard androgen suppression therapy for advanced prostate cancer A systematic review with meta-analysis

Gonadotropin-releasing hormone antagonists versus standard androgen suppression therapy for advanced prostate cancer: A systematic review with meta-analysis

Prognostic impact of urokinase-type plasminogen activator system components in clear cell renal cell carcinoma patients without distant metastasis

Role of miRs in immune suppression

Prognostic impact of urokinase-type plasminogen activator system components in clear cell renal cell carcinoma patients without distant metastasis

Genetik von Krankheiten des Urogenitalsystems

Genetik von Krankheiten des Urogenitalsystems : mit 36 Tabellen

Heilung von Gastroentero-Anastomosen und Bauchdeckenwunden unter perioperativer Gabe der Zytostatika-Kombination FAM (5-Fluor-Uracil [Fluor-Uracil], Adriamycin, Mitomycin C) : e. biomechan. u. histolog. Unters. an Wistar-Ratten